ArticleJournal of clinical medicine2021

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients.

Joanna Barankiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.